Bearbmagovva

Improving the quality of cancer clinical trials workshop summary /

Furkejuvvon:
Bibliográfalaš dieđut
Searvvušdahkkit: National Cancer Policy Forum (U.S.), Institute of Medicine (U.S.), ebrary, Inc
Eará dahkkit: Patlak, Margie, Nass, Sharyl J.
Materiálatiipa: Elektrovnnalaš E-girji
Giella:eaŋgalasgiella
Almmustuhtton: Washington, D.C. : National Academies Press, c2008.
Fáttát:
Cancer > Treatment > United States.
Clinical trials.
Electronic books.
Liŋkkat:An electronic book accessible through the World Wide Web; click to view
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
Sisdoallologahallan:
  • Introduction
  • New clinical trial designs. Phase 0 trials
  • Adaptive trial designs
  • Targeting multiple pathways with multiple drugs
  • Preclinical model systems
  • Molecular imaging. Current and developing methods
  • Challenges of molecular imaging
  • Screening for predictive markers. The challenges of clinical validation
  • Bioimaging predictive markers
  • Clinical translation
  • Panel discussion
  • Costs of clinical trials. Regulatory costs
  • Patient accrual
  • Global outsourcing
  • Time is money
  • Public-private collaborations
  • Regulatory issues. Regulatory barriers to innovation
  • Patient advocacy perspective
  • Regulation of in vitro diagnostics
  • Regulatory issues in improving cancer clinical trials
  • Reports from the case study discussion groups. Adaptive trial design
  • Phase 0 trials
  • Imaging
  • Use of proteomics/genomics to assign therapy in lung cancer
  • Use of genetics/genomics to assign therapy.

Geahča maid